SPAC212.02 Antibody

What is SPAC212.02 and why is it significant in S. pombe research?

SPAC212.02 is a gene sequence in Schizosaccharomyces pombe that encodes a protein involved in cell wall formation. The protein shows significant homology to Saccharomyces cerevisiae Kre9, which plays a crucial role in β-1,6-glucan synthesis . Research indicates that this protein is essential for proper cell wall integrity and septum formation in fission yeast. The significance lies in its fundamental role in maintaining cell morphology and division, making it an important target for understanding basic cellular processes in fungi .

How does Sup11p (the protein product of SPAC212.02) function in cell wall formation?

Sup11p functions as a key component in β-1,6-glucan synthesis, which is essential for cell wall integrity in S. pombe. Studies have demonstrated that depletion of Sup11p results in the absence of β-1,6-glucan from the cell wall . The protein is indispensable for proper septum assembly, and mutants with reduced sup11+ expression exhibit severe morphological defects including malformation of the septum with massive accumulation of cell wall material at the center of the closing septum . These accumulations partially consist of β-1,3-glucan, which should normally be restricted to the primary septum, suggesting that Sup11p plays a regulatory role in polysaccharide distribution during septum formation .

What are the optimal fixation methods for immunodetection of SPAC212.02 protein products in S. pombe?

For effective immunodetection of SPAC212.02 protein products in S. pombe, methanol fixation has proven successful in preserving protein epitopes while allowing antibody accessibility. Based on protocols described in the literature, cells should be fixed with cold methanol (-20°C) for 8-10 minutes followed by washing with phosphate-buffered saline (PBS) . This method preserves cellular morphology while maintaining antigen recognition sites. For subcellular localization studies, combining this fixation with immunofluorescence labeling using antibodies against SPAC212.02 protein products allows visualization of protein distribution patterns within the cell . For higher resolution analysis, immunogold electron microscopy can be employed following aldehyde fixation and low-temperature embedding to preserve antigenicity while enabling ultrastructural localization .

How can researchers distinguish between different functional domains of the SPAC212.02 protein using domain-specific antibodies?

Researchers can generate domain-specific antibodies by designing peptide antigens corresponding to distinct functional regions of the SPAC212.02 protein. Based on in silico analysis of Sup11p structure, the protein contains several key domains including a signal peptide, a transmembrane domain, and S/T-rich regions prone to O-mannosylation .

To generate domain-specific antibodies, researchers should:

• Perform bioinformatic analysis to identify conserved and accessible epitopes within each domain

• Synthesize peptides (15-20 amino acids) corresponding to these regions

• Conjugate peptides to carrier proteins (like KLH or BSA)

• Immunize suitable host animals (rabbits for polyclonal or mice for monoclonal)

• Purify antibodies using antigen affinity columns

For validation, western blotting should be performed using mutant constructs with specific domain deletions. Immunoprecipitation followed by mass spectrometry can confirm antibody specificity and identify interacting partners for each domain .

What are the critical controls needed when using SPAC212.02 antibodies in co-immunoprecipitation experiments to identify protein interaction partners?

When designing co-immunoprecipitation (co-IP) experiments with SPAC212.02 antibodies to identify protein interaction partners, several critical controls must be implemented:

• Negative controls:

  • Perform parallel immunoprecipitation with pre-immune serum or isotype-matched irrelevant antibodies

  • Include a wild-type strain and a strain with depleted SPAC212.02 expression (like the nmt81-sup11 conditional mutant)

  • Use beads-only controls to identify non-specific binding to the matrix

• Validation controls:

  • Confirm the presence of known interacting proteins (e.g., components of β-1,6-glucan synthesis machinery)

  • Perform reciprocal co-IPs with antibodies against identified interaction partners

  • Include crosslinking controls with varying crosslinker concentrations to capture transient interactions

• Specificity verification:

  • Use competing peptides to block specific antibody binding

  • Validate interactions using alternative methods (yeast two-hybrid, proximity ligation assay)

  • Perform subcellular fractionation to confirm that interacting proteins co-localize in the same cellular compartments

Mass spectrometry analysis of co-immunoprecipitated proteins should be accompanied by spectral counting or SILAC approaches to quantify enrichment relative to controls .

How can epitope tagging of SPAC212.02 affect protein localization and function in S. pombe?

Epitope tagging of SPAC212.02 can significantly impact protein localization and function in S. pombe, requiring careful experimental design. Studies have shown that both C- and N-terminal tagging of Sup11p with various fluorochromes can affect protein functionality . The available data indicates:

• Tag position effects:

  • N-terminal tagging may interfere with signal peptide function, disrupting proper membrane insertion

  • C-terminal tagging can affect protein-protein interactions at the C-terminus

• Tag size considerations:

  • Larger tags (GFP, mCherry) are more likely to disrupt protein folding and function

  • Smaller tags (HA, FLAG, Myc) generally cause fewer functional perturbations but provide less sensitivity for microscopy

• Functional validation requirements:

  • Tagged constructs must be tested for complementation of the lethal phenotype of sup11+ deletion

  • Growth assays under stress conditions (e.g., cell wall-perturbing agents) should be performed

  • Cell wall composition analysis should be conducted to ensure normal β-1,6-glucan synthesis

Research has demonstrated that Sup11p:HA is O-mannosylated, and this modification affects protein stability. When expressed in O-mannosylation-deficient backgrounds, Sup11p exhibits altered glycosylation patterns, including unusual N-glycosylation on an N-X-A sequon that is normally masked by O-mannosylation .

How should researchers design experiments to study the effects of SPAC212.02 depletion on cell wall integrity?

Designing experiments to study SPAC212.02 depletion effects on cell wall integrity requires a multi-faceted approach:

• Genetic manipulation strategies:

  • Use a conditionally lethal system like the nmt81-sup11 knock-down mutant, which allows for controlled gene expression

  • Create temperature-sensitive alleles for acute inactivation studies

  • Consider CRISPR-based degron systems for rapid protein depletion

• Cell wall integrity assessment methods:

  • Microscopic analysis: Phase contrast, electron microscopy, and fluorescence microscopy with cell wall dyes (Aniline blue for β-1,3-glucan)

  • Biochemical analysis: Quantification of β-1,6-glucan and other cell wall components

  • Cell sensitivity assays: Test sensitivity to cell wall-perturbing agents (Calcofluor White, Congo Red)

• Temporal considerations:

  • Time-course experiments to distinguish primary from secondary effects

  • Synchronize cells to examine cell-cycle-specific requirements

• Comprehensive data collection:

  • Perform transcriptome analysis to identify affected pathways (as demonstrated with the nmt81-sup11 mutant)

  • Analyze changes in cell wall protein composition

  • Examine alterations in β-glucan partitioning in the septum and lateral cell wall

Research has shown that Sup11p depletion causes significant changes in cell wall composition, with pronounced effects on β-1,6-glucan content and septum formation .

What approaches are most effective for analyzing antibody specificity against SPAC212.02-encoded proteins?

To effectively analyze antibody specificity against SPAC212.02-encoded proteins, researchers should implement a comprehensive validation strategy:

• Western blot validation:

  • Compare protein detection in wild-type and sup11+ deletion strains complemented with plasmid-borne sup11+

  • Analyze size shifts with epitope-tagged versions of the protein

  • Examine changes in protein levels in conditional expression systems (e.g., nmt81-sup11)

• Immunoprecipitation validation:

  • Perform mass spectrometry on immunoprecipitated proteins to confirm identity

  • Conduct peptide competition assays with the immunizing antigen

  • Use affinity-purified antibodies to reduce non-specific binding

• Immunofluorescence controls:

  • Compare staining patterns between wild-type and depletion strains

  • Conduct pre-adsorption controls with purified antigen

  • Perform dual labeling with antibodies against known compartment markers to confirm localization

• Cross-reactivity assessment:

  • Test antibodies against related proteins (e.g., other members of the Kre9 family)

  • Evaluate specificity across species if working with antibodies raised against homologous proteins

Research with Sup11p demonstrates that affinity purification of polyclonal antibodies raised against GST-fusion peptides significantly improves specificity for immunodetection applications .

How can researchers effectively study post-translational modifications of SPAC212.02 protein products?

Studying post-translational modifications (PTMs) of SPAC212.02 protein products requires specialized techniques tailored to detect specific modifications:

• Glycosylation analysis:

  • EndoH treatment followed by Western blotting to detect N-glycosylation

  • PAS-Silver staining to visualize glycoproteins

  • Mass spectrometry with electron transfer dissociation (ETD) to preserve and identify glycan structures

  • Expression in glycosylation-deficient mutants (oma2, oma4) to study glycosylation dependencies

• Membrane topology and modification accessibility:

  • Proteinase K protection assays to determine protein orientation and accessibility of modification sites

  • Site-directed mutagenesis of potential modification sites followed by functional assays

• Quantitative PTM analysis:

  • Phosphorylation site mapping using titanium dioxide enrichment and mass spectrometry

  • Targeted mass spectrometry using selected reaction monitoring (SRM) to quantify specific modified peptides

  • Comparison of modification patterns between wild-type and mutant backgrounds

Research has demonstrated that Sup11p:HA is O-mannosylated in wild-type cells but undergoes unusual N-glycosylation on an N-X-A sequon in the oma4 mutant background. This sequon is normally located in an S/T-rich region that is heavily O-mannosylated, masking it from N-glycosylation machinery .

How should researchers interpret discrepancies between immunofluorescence and biochemical localization data for SPAC212.02 proteins?

When faced with discrepancies between immunofluorescence and biochemical localization data for SPAC212.02 proteins, researchers should consider:

• Technical limitations of each method:

  • Immunofluorescence may not detect low abundance proteins or those in certain compartments

  • Biochemical fractionation can lead to cross-contamination between cellular compartments

  • Epitope accessibility may differ between techniques

• Systematic validation approach:

  • Perform subcellular fractionation via sucrose density gradient centrifugation with immunoblotting for compartment-specific markers

  • Use multiple independent antibodies or different epitope tags

  • Employ super-resolution microscopy techniques for improved spatial resolution

  • Correlate results with functional data (e.g., genetic interactions)

• Dynamic localization considerations:

  • Examine protein localization throughout the cell cycle

  • Consider stress conditions that might alter localization

  • Evaluate the possibility of protein shuttling between compartments

Research on Sup11p localization has involved multiple complementary approaches, including fluorescent protein tagging, immunofluorescence, and cellular fractionation. These studies suggested that Sup11p resides in late Golgi or post-Golgi vesicles, aligning with its role in β-1,6-glucan synthesis .

What strategies are recommended for optimizing western blot protocols when working with difficult-to-detect SPAC212.02 protein variants?

When optimizing western blot protocols for difficult-to-detect SPAC212.02 protein variants, researchers should consider:

• Sample preparation optimization:

  • Use specialized membrane preparation protocols developed for S. pombe

  • Implement protease inhibitor cocktails optimized for yeast systems

  • Consider mild detergents for membrane protein solubilization

  • Avoid excessive heating of samples containing transmembrane domains

• Transfer and detection enhancements:

  • Optimize transfer conditions for high molecular weight or hydrophobic proteins

  • Utilize PVDF membranes for improved protein binding

  • Implement wet transfer for membrane proteins

  • Consider adding SDS (0.1%) to transfer buffer for hydrophobic proteins

• Signal amplification strategies:

  • Use high-sensitivity chemiluminescent substrates

  • Employ biotin-streptavidin systems for signal enhancement

  • Consider tyramide signal amplification for very low abundance proteins

  • Optimize antibody concentrations through titration

• Special considerations for glycosylated variants:

  • Account for heterogeneous banding patterns due to differential glycosylation

  • Include deglycosylation controls (EndoH treatment)

  • Compare migration patterns between wild-type and glycosylation-deficient backgrounds

Research has shown that detection of Sup11p requires careful optimization of membrane preparation and western blot conditions, particularly when examining its glycosylation state in different genetic backgrounds .

How might CRISPR-Cas9 genome editing be applied to study SPAC212.02 function in S. pombe?

CRISPR-Cas9 genome editing offers powerful new approaches to study SPAC212.02 function in S. pombe:

• Precise genetic modification strategies:

  • Generate point mutations to identify critical functional residues

  • Create domain deletions to assess domain-specific functions

  • Introduce fluorescent protein tags at the endogenous locus

  • Establish conditional alleles through insertion of degron tags

• Experimental design considerations:

  • Select guide RNAs with minimal off-target effects

  • Design repair templates with appropriate homology arms

  • Include selection markers that can be subsequently removed

  • Verify edits by sequencing and functional complementation

• Advanced applications:

  • Perform CRISPR interference (CRISPRi) for tunable gene repression

  • Implement CRISPR activation (CRISPRa) to upregulate expression

  • Create screening libraries targeting potential interaction partners

  • Generate epitope-tagged versions for ChIP-seq or protein-protein interaction studies

What are the implications of SPAC212.02/Sup11p glycosylation for protein function and antibody development?

The glycosylation of SPAC212.02/Sup11p has significant implications for both protein function and antibody development:

• Functional implications of glycosylation:

  • O-mannosylation stabilizes Sup11p, as shown by altered protein levels in O-mannosylation mutants

  • Glycosylation may protect specific domains from proteolytic degradation

  • Post-translational modifications can regulate protein-protein interactions

  • Competition between N- and O-glycosylation pathways can occur, as demonstrated by unusual N-glycosylation in oma4 mutants

• Considerations for antibody development:

  • Epitope selection should consider glycosylation sites to avoid masked epitopes

  • Different antibodies may be needed to detect glycosylated versus unglycosylated forms

  • Validation should include tests in glycosylation-deficient backgrounds

  • Antibodies raised against peptides may not recognize native, glycosylated proteins

• Glycosylation-related experimental approaches:

  • Analyze glycosylation patterns using mass spectrometry

  • Study glycosylation site mutants to determine functional significance

  • Compare protein stability and localization in glycosylation-deficient backgrounds

Research has demonstrated that Sup11p is subject to both O-mannosylation and, under certain conditions, N-glycosylation. The protein contains an unusual N-X-A sequon located within an S/T-rich region that is normally heavily O-mannosylated, preventing N-glycosylation in wild-type cells .

How do transcriptional changes following SPAC212.02/Sup11p depletion provide insights into its regulatory networks?

Transcriptional changes following SPAC212.02/Sup11p depletion offer valuable insights into its regulatory networks:

• Major affected pathways and processes:

  • Oligosaccharide catabolic processes show significant regulation

  • Cell wall protein genes exhibit altered expression patterns

  • The septum separation pathway is transcriptionally affected

• Specific gene regulation patterns:

  • β-1,3-glucanosyl-transferases of the GH72 family (particularly Gas2p) show significant regulation

  • Cell wall glucan-modifying enzymes demonstrate altered expression

  • Several cell wall proteins display changes in abundance

• Network analysis approaches:

  • Construct interaction networks based on co-regulated genes

  • Identify transcription factors potentially mediating the observed changes

  • Compare transcriptional profiles with other cell wall mutants to identify common and unique signatures

• Validation strategies:

  • Confirm key expression changes through qPCR

  • Perform ChIP-seq to identify direct regulatory interactions

  • Conduct genetic interaction studies with identified targets

Transcriptome analysis of the nmt81-sup11 mutant revealed that Gas2p, a member of the β-1,3-glucanosyl-transferases GH72 family, plays a crucial role in the accumulation of septum material depositions observed in Sup11p-depleted cells .

How does the function of SPAC212.02/Sup11p in S. pombe compare to its homologs in other fungi, particularly S. cerevisiae Kre9?

Comparative analysis of SPAC212.02/Sup11p with fungal homologs reveals important evolutionary and functional relationships:

• Structural and functional conservation:

  • Sup11p shows significant homology to Saccharomyces cerevisiae Kre9, which is involved in β-1,6-glucan synthesis

  • Despite this homology, there are notable differences in essentiality – sup11+ is essential in S. pombe, while KRE9 in S. cerevisiae is not essential when its homolog KNH1 is present

• Localization comparisons:

  • Kre-family proteins localize to secretory pathway compartments from the endoplasmic reticulum to the plasma membrane

  • Sup11p specifically localizes to late Golgi or post-Golgi vesicles in S. pombe

  • This conservation of localization suggests similar roles in the secretory pathway

• Functional context differences:

  • Both proteins function in β-1,6-glucan synthesis, but their interactions with other cellular components may differ

  • The relative importance of β-1,6-glucan in cell wall architecture varies between fungal species

  • Differential genetic interactions may reflect adaptation to species-specific cell wall requirements

• Evolutionary implications:

  • Conservation of this protein family across divergent fungi suggests fundamental importance in fungal cell wall biogenesis

  • Species-specific differences highlight evolutionary adaptations in cell wall architecture and regulation

The resemblance between Sup11p and Kre9 provides a framework for understanding β-1,6-glucan synthesis mechanisms across fungal species, while the differences offer insights into species-specific adaptations in cell wall architecture .